Mingjiang Xu
- Hepatology top 2%
- Liver Disease and Transplantation 4
- Liver physiology and pathology 2
-
- Alcohol Consumption and Health Effects 12
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 14
- Cancer Research top 10%
- Immunology top 10%
- Immune Response and Inflammation 3
- Immune Cell Function and Interaction 2
-
- Eicosanoids and Hypertension Pharmacology 5
-
- Diet, Metabolism, and Disease 3
- Partner nations
- United StatesChinaSpain
In The Last Decade
Mingjiang Xu
33 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 104
- Hepatology 299
- Pathology and Forensic Medicine 546
- Epidemiology 959
- Cancer Research 239
- Immunology 329
Countries citing papers authored by Mingjiang Xu
This map shows the geographic impact of Mingjiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjiang Xu more than expected).
Fields of papers citing papers by Mingjiang Xu
This network shows the impact of papers produced by Mingjiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjiang Xu. The network helps show where Mingjiang Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingjiang Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 31 | |
| 5 | 2022 | 48 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 50 | |
| 9 | 2018 | 131 | |
| 10 | MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6–p47phox–oxidative stress pathway in neutrophils | 2017 | 19 |
| 11 | 2017 | 6 | |
| 12 | 2017 | 62 | |
| 13 | 2017 | 64 | |
| 14 | 2017 | 89 | |
| 15 | 2017 | 59 | |
| 16 | 2016 | 184 | |
| 17 | 2016 | 48 | |
| 18 | 2014 | 22 | |
| 19 | 2014 | 11 | |
| 20 | 2014 | 35 |
About Mingjiang Xu
Mingjiang Xu is a scholar working on Pathology and Forensic Medicine, Biochemistry and Hepatology, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (14 papers), Alcohol Consumption and Health Effects (12 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Liver Disease and Transplantation (4 papers), Diet, Metabolism, and Disease (3 papers), Immune Response and Inflammation (3 papers), Liver physiology and pathology (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hepatology (299 citations), Pathology and Forensic Medicine (546 citations) and Epidemiology (959 citations). Mingjiang Xu has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Bin Gao, Zhou Zhou, Yan Cai, Dechun Feng, Hua Wang, Adeline Bertola, Yong He, Zhou Zhou, Suthat Liangpunsakul and Haixia Cao. Their work appears in journals such as Hepatology, Gut and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.